Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?
- S. L. Yeoh; G. T. Flaherty Fatty liver disease in obese patients with COVID-19: a tale of two pandemics? Eur J Prev Cardiol
NAFLD
Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer
- F. Donohoe; M. Wilkinson; E. Baxter; D. J. Brennan Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer Int J Mol Sci
Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device
- J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine
Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease
- A. P. Belgaumkar; R. P. Vincent; K. A. Carswell; R. D. Hughes; J. Alaghband-Zadeh; R. R. Mitry; C. W. le Roux; A. G. Patel Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease Obes Surg